U.S. Markets closed

Cooper Companies to acquire Saulfon Pharmaceuticals for $1.2B

The Cooper Companies announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals, a European manufacturer and distributor of soft contact lenses and solutions, in a transaction valued at approximately $1.2B. Sauflon forecasts revenue of approximately $210M for FY14, up approximately 22% year-over-year. Excluding one-time charges and deal-related amortization, the transaction is expected to be accretive to EPS in FY15. The acquisition will be financed with off-shore cash and credit facilities.